Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia
Karni S Moshal1, Naira Metreveli, Iuliana Frank
1Department of Physiology and Biophysics, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Insights
Hyperhomocysteinemia (HHcy) impairs heart function by activating NMDA receptors and causing mitochondrial dysfunction. This review explores how homocysteine (Hcy) exacerbates cardiac issues via mitochondrial pathways.
Area of Science:
- Cardiology
- Mitochondrial Biology
- Neurocardiology
Background:
- Chronic heart failure involves oxidative stress and matrix metalloproteinase activation, leading to endothelial-myocyte uncoupling and impaired cardiac function.
- Elevated homocysteine (Hcy) levels, or hyperhomocysteinemia (HHcy), are linked to reduced cardiac performance, ventricular hypertrophy, cardiac stiffness, and diastolic heart failure.
- While N-methyl-D-aspartate receptors (NMDA-R) are implicated in Hcy-induced neurological defects and are present in the heart, their role in cardiac function during HHcy is not well understood.
Purpose of the Study:
- To elucidate the mitochondrial mechanisms by which Hcy contributes to the decline in cardiac mechano-electrical function and arrhythmogenesis through NMDA-R activation.
- To discuss the role of mitochondrial membrane potential (MMP) activation, protease stress, and mitochondrial permeability transition in cardiac conduction during HHcy.
- To investigate the potentiation between NMDA-R activation and mitochondrial defects in causing cardiac dysfunction during HHcy.
Main Methods:
- Review of existing literature on hyperhomocysteinemia, oxidative stress, NMDA receptor activation, and mitochondrial function in the context of heart failure.
- Analysis of the molecular pathways linking Hcy, NMDA-R, intracellular calcium handling, and mitochondrial dysfunction.
- Discussion of the role of cyclophilin D and the mitochondrial permeability transition pore in HHcy-induced cardiac pathology.
Main Results:
- Hcy increases intracellular calcium levels, activates calpain, and leads to mitochondrial abnormalities.
- Mitochondrial permeabilization and uncoupling in HHcy are driven by redox stress and calcium mishandling.
- Hcy amplifies mitochondrial membrane potential (mtMMP) activation via increased mitochondrial calcium overload and oxidative stress, leading to opening of the mitochondrial permeability transition pore.
Conclusions:
- Hcy-induced NMDA-R activation contributes to cardiac dysfunction and arrhythmogenesis through mitochondrial pathways.
- Mitochondrial dysfunction, including mtMMP activation and pore opening, plays a critical role in the mechano-electrical dysfunction observed in HHcy.
- Targeting NMDA-R and mitochondrial pathways may offer therapeutic strategies for managing HHcy-related cardiac complications.
Abstract:
Chronic volume/pressure overload-induced heart failure augments oxidative stress and activates matrix metalloproteinase which causes endocardial endothelial-myocyte (EM) uncoupling eventually leading to decline in myocardial systolic and diastolic function. The elevated levels of homocysteine (Hcy), hyperhomocysteinemia (HHcy), are associated with decline in cardiac performance. Hcy impairs the EM functions associated with the induction of ventricular hypertrophy leading to cardiac stiffness and diastolic heart failure. Hcy-induced neurological defects are mediated by the NMDA-R (N-methyl-D-aspartate (NMDA) receptor) activation. NMDA-R is expressed in the heart. However, the role of NMDA-R on cardiac function during HHcy is still in its infancy. The blockade of NMDA-R attenuates NMDA-agonist-induced increase in the heart rate. Hcy increases intracellular calcium and activates calpain and calpain-associated mitochondrial (mt) abnormalities have been identified in HHcy. Mitochondrial permeabilization and uncoupling in the pathological setting is fueled by redox stress and calcium mishandling. Recently the role of cyclophilin D, a component of the mitochondrial membrane permeability transition pore, has been identified in cardiac-ischemia. Mechanisms underlying the potentiation between NMDA-R activation and mitochondrial defects leading to cardiac dysfunction during HHcy remain to be elucidated. This review addresses the mitochondrial mechanism by which Hcy contributes to the decline in mechano-electrical function and arrhythmogenesis via agonizing NMDA-R. The putative role of mitochondrial MMP activation, protease stress and mitochondrial permeability transition in cardiac conduction during HHcy is discussed. The review suggests that Hcy increases calcium overload and oxidative stress in the mitochondria and amplifies the activation of mtMMP, causing the opening of mitochondrial permeability transition pore leading to mechano-electrical dysfunction.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
ATP Synthase: Mechanism
Cardiomyopathy I: Introduction and Classification
Myocarditis I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

